AbstractNovel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders. Other References- Gennaro, et al., Eds., "Remington: The Science and Practice of Pharmacy", Mack Printing Company, Easton, Pennsylvania (1995)
- Kaiser et al., "Factor Xa Inhibitors as Novel Antithrombotic Agents: Facts and Perspectives," Cardiovascular Drug Reviews, 12(3):225-236 (1994)
- Robl, et al., "Dual Metalloprotease Inhibitors. II. Effect of Substitution and Stereochemistry on Benzazepinone Based Mercaptoacetyls," Bioorganic and Medicinal Chemistry Letters 4(15):1795-1800 (1994)
- Robl, et al., "Dual Metalloprotease Inhibitors. 6. Incorporation of Bicyclic and Substituted Monocyclic Azepinones as Dipeptide Surrogates in Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitors," Journal of Medicinal Chemistry, 39(2):494-502 (1996)
- Semple, et al., "Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-argininal derivatives incorporating P3-4 lactam sulfonamide moieties", J. Med. Chem. 39:4531-4536 (1996)
- Skiles, et al., Bioorganic & Medicinal Chemistry Letters, 3(4):773-778 (1993)
- Skiles, et al., Chemical Abstracts, vol. 120, No. 11, (1994) (CA: 120:135101a)
- Tourwe, et al., "Conformational Restriction of Tyr and Phe Side Chains in Opioid Peptides: Information About Preferred and Bioactive Side-Chain Topology", Biopolymers 38:1-12 (1996)
- Almquist et al., "Synthesis and Biological Activity of a Ketamethylene Analogue of a Tripeptide Inhibitor of Angiotensin Converting Enzyme", J. Med. Chem. 23:1392-1398 (1980)
- Blankenship et al., "Amino Acid Sequence of Ghilanten: Anticoagulant-Antimetastatic Principle of the South American Leech, Haementeria ghilianii", Biochem, BioPhys. Res. Commun. 166:1384-1389 (1990)
- Bodanszky, "The Principles of Peptide Synthesis", Hafner, et al., Eds., Springer-Verlag, Berlin (1984) Book Table of Contents Only
- Brankamp et al., "Ghilantens: Anticoagulants Antimetastatic Proteins from the South American Leech, Haementeria ghilianii", J. Lab. Clin. Med. 115:89-97 (1990)
- Bundgard, "Design of Pro-drugs", pp. 7-9, Elsevier, Amsterdam, 1985
- Bundgard, "Design of Pro-drugs", pp. 21-24, Elsevier, Amsterdam, 1985
- Szelke et al., CA:97:39405 (1982)
- Cappello et al., "Ancylostoma Factor Xa Inhibitor: Partial Purification and its Identification as a Major Hookworm-derived Anticoagulant in Vitro", J. Infect. Dis. 167:1474-1477 (1993)
- Claeson, "Synthetic Peptides and Peptidomimetics as Substrates and Inhibitors of Thrombin and Other Proteases in the Blood Coagulation System", Blood Coag. Fibrinol. 5:411-436 (1994)
- Condra et al., "Isolation and Structural Characterization of a Potent Inhibitor of Coagulation Factor Xa from the Leech Haementeria ghilianii" Thromb. Haemost. 61:437-441 (1989)
- Cox, "Coagulation Factor X Inhibitor from the Hundred-pace Snake (Deinagkistrodon Acutus) Venom", Toxicon 31:1445-1457 (1993)
- Davie et al., "The Coagulation Cascade: Initiation, Maintenance and Regulation", Biochemistry 30:10363-10370 (1991)
- Diana, et al., "Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect against Hepatic Metabolism", J. Med. Chem. 38:1355-1371 (1995)
- Diana, et al., "Oxadiazaoles as Ester Bioisosteric Replacements in Compounds Related to Disoxaril. Antirhinovirus Activity", J. Med. Chem. 37:2421-2436 (1994)
- DiMaio et al., "Synthesis of Chiral Piperazin-2-ones as Model Peptidomimetics", J. Chem. Soc. Perkins. Trans. I, 1687-1689 (1989)
- Edwards et al., "Design, Synthesis, and Kinetic Evaluation of a Unique Class of Elastase Inhibitors, the Peptidyl -Ketobenzoxazoles, and the X-ray Crystal Structure of the Covalent Complex between Porcine Pancreatic Elastase and Ac-Ala-Pro-Val-2-Benzoxazole", J. Am. Chem. Soc. 114:1854-1863 (1992)
- Edwards et al., "Peptidyl -Ketoheterocyclic Inhibitors of Human Neutrophil Elastase. 2. Effect of Varying the Heterocyclic Ring on in Vitro Potency", J. Med. Chem. 38:76-85 (1995)
- Girard et al., "Functional Significance of the Kunitz-type Inhibitory Domains of Lipoprotein-associated Coagulation Inhibitor", Nature 338:518-520 (1989)
- Gross et al., Eds., "The Peptides: Analysis, Synthesis, Biology", Academic Press, vol. 3 (1981) Book Table of Contents Only
- Udenfriend et al., Eds., "The Peptides: Analysis, Synthesis, Biology", Academic Press, vol. 9 (1977) Book Table of Contents Only
- Hann, J. Chem. Soc. Perkins. Trans. I, pp. 307-314 (1982)
- Hauptmann et al., "Comparison of the Anticoagulant and Antithrombotic Effects of Synthetic Thrombin and Factor Xa Inhibitors", Thromb. Haemost. 63:220-223 (1990)
- Hitomi et al., "Inhibitory Effect of New Synthetic Protease Inhibitor (FUT-175) on the Coagulation System", Haemostatsis 15:164-168 (1985)
- Hollenbach et al., "A Comparative Study of Prothrombinase and Thrombin Inhibitors in a Novel Rabbit Model of Non-Occlusive Deep Vein Thrombosis", Thromb. Haemost. 71:357-362 (1992)
- Holladay et al., "Synthesis of Hydroxyethylene and Ketomethylene Dipeptide Isosteres", Tetrahedron Lett. 24:4401-4404 (1983)
- Hruby, "Conformational Restrictions of Biologically Active Peptides via Amino Acid Side Chain Groups", Life Sci. 31:189-199 (1982)
- Hudson, et al., "Methionine Enkephalin and Isosteric Analogues", Int. J. Pept. Prot. Res. 14:177-185 (1979)
- Jacobs et al., "Isolation and Characterization of a Coagulation Factor Xa Inhibitor from Black Fly Salivary Glands", Thromb. Haemost. 64:235-238 (1990)
- Jennings-White et al., "Synthesis of Ketomethylene Anaolgs of Dipeptides", Tetrahedron Lett. 23:2533-2534 (1982)
- Kam et al., "Mechanism-based Isocoumarin Inhibitors for Trypsin and Blood Coagulation Serine Proteases: New Anticoagulants", Biochemistry 27:2547-2557 (1988)
- Kojima et al., "Preparations, Solution Conformations and Molecular Structures of N, N'-Ethylene-bridged Dipeptides and their Derivatives", Int. J. Peptide Protein Res. 37:468-475 (1991)
- Mann, et al., "Surface-Dependent Reactions of the Vitamin K-Dependent Enzyme Complexes", Blood 76:1-16 (1990)
- Morley, "Modulation of the Action of Regulatory Peptides by Structural Modification", (General Review) Trends Pharm. Sci. pp. 463-468 (1980)
- Nagahara et al., "Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa Inhibitors", J. Med. Chem. 37:1200-1207 (1994)
- Nutt et al., "The Amino Acid Sequence of Antistasin: A Potent Inhibitor of Factor Xa Reveals a Repeated Internal Structure", J. Biol. Chem. 263:10162-10167 (1988)
- Seymour et al., "Ecotin Is A Potent Anticoagulant and Reversible Tight-binding Inhibitor of Factor Xa", Biochemistry 33:3949-3958 (1994)
- Silverman, "The Organic Chemistry of Drug Design and Drug Action", pp. 352-401, Academic Press, San Diego, CA. (1992)
- Sinha et al., "Effect of Gamma Carboxylation on Prothrombinase Inhibitory Activity of Catalytically Inactive Factor Xa", Thromb. Res. 75:427-436 (1994)
- Spatola et al., "Structure-Activity Relationship of Enkephalins Containing Serially Replaced Thiomethylene Amide Bond Surrogates", Life Sci. 38:1243-1249 (1986)
- Spatola, "Chemistry and Biochemistry of Amino Acids, Peptides and Proteins", (General Review), B. Weinstein, Eds., Marcell Decker, New York, p. 260. (1983)
- Sturzebecher et al., "Synthetic Inhibitors of Bovine Factor Xa and Thrombin. Comparison of Their Anticoagulant Efficiency", Thromb. Res. 54:245-252 (1989)
- Tidwell et al., "Strategies for Anticoagulation with Synthetic Protease Inhibitors. Xa Inhibitors Versus Thrombin Inhibitors", Thromb. Res. 19:339-349 (1980)
- R. Tomatis, et al., "Synthesis and pharmacological activity of Leu-Enkephalins modified at Gly 2 -Gly 3 nitrogens," European Journal of Medicinal Chemistry--Chimica Therapeutica, vol. 16, No. 3, pp. 229-232 (1981)
- Turner et al., "p-Amidino Esters as Irreversible Inhibitors of Factor IXa and Xa and Thrombin", Biochemistry 25:4929-4935 (1986)
- Tsutsumi, et al., "Synthesis and Structure-Activity Relationships of Peptidyl -Keto Heterocycles as Novel Inhibitors of Prolyl Endopeptidase", J. Med. Chem. 37:3492-3502 (1994)
- Waxman et al., "Tick Anticoagulant Peptide (Tap) Is a Novel Inhibitor of Blood Coagulation Factor Xa", Science 248:593-596 9 (1990)
- Wityak, et al., "Synthesis of Thrombin Inhibitor DuP 714", J. Org. Chem. 60:3717-3722 (1995)
- Stilz et al., "Discovery Of An Orally Active Non-Peptide Fibrinogen Receptor Antagonist", J. Med. Chem., vol. 39, No. 11, pp. 2118-2122 (1996)
- Kunitada et al., "Factor Xa Inhibitors", Current Pharmaceutical Design, vol. 2, No. 5, pp. 531-542 (1996
| InventorsApplication No. 058565 filed on 04/13/1998 US Classes:514/254.02, The additional five-membered hetero ring also has chalcogen as a ring member514/64, Boron containing DOAI514/211.15, Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding514/217.05, Plural ring hetero atoms in the additional hetero ring514/235.8, Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)514/253.1, The five-membered nitrogen hetero ring has chalcogen as a ring member540/598, Plural hetero atoms in the additional hetero ring544/121, Piperazine ring544/229, Boron or silicon containing544/357, Plural diazine rings544/360, Six-membered ring consisting of one nitrogen and five carbons (e.g., pyridine, etc.)544/363, Quinoline or isoquinoline (including hydrogenated)544/364, At least three hetero rings containing544/368, The five-membered hetero ring is one of the cyclos in a polycyclo ring system544/369, 1,3-oxazole ring or 1,3-thiazole ring (including hydrogenated)544/384, Chalcogen bonded directly to piperazine ring carbon544/385Plural chalcogens bonded directly to piperazine ring carbonsField of Search514/64, Boron containing DOAI514/235.8, Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)514/217.05, Plural ring hetero atoms in the additional hetero ring514/254.02, The additional five-membered hetero ring also has chalcogen as a ring member514/253.1, The five-membered nitrogen hetero ring has chalcogen as a ring member540/598, Plural hetero atoms in the additional hetero ring544/121, Piperazine ring544/229, Boron or silicon containing544/357, Plural diazine rings544/360, Six-membered ring consisting of one nitrogen and five carbons (e.g., pyridine, etc.)544/363, Quinoline or isoquinoline (including hydrogenated)544/364, At least three hetero rings containing544/368, The five-membered hetero ring is one of the cyclos in a polycyclo ring system544/369, 1,3-oxazole ring or 1,3-thiazole ring (including hydrogenated)544/384, Chalcogen bonded directly to piperazine ring carbon544/385Plural chalcogens bonded directly to piperazine ring carbonsExaminers Primary: Raymond, Richard L. Assistant: Coleman, BrendaAttorney, Agent or FirmUS Patent References 3352866, 3845046, 4178438, Cationically modified, cellulose-containing materials Issued on: 12/11/1979 Inventor: Haase , et al.4251438, Piperazinone and piperazine polypeptides Issued on: 02/17/1981 Inventor: Moon4341698, Enkaphalin derivatives Issued on: 07/27/1982 Inventor: Carr , et al.4588587, Method of treatment to inhibit metastasis Issued on: 05/13/1986 Inventor: Gasic4720493, Thienylthiazole compounds Issued on: 01/19/1988 Inventor: Kawakita , et al.5028610, N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use Issued on: 07/02/1991 Inventor: Hirai, et al.5120718, Candida acid protease inhibiting compounds Issued on: 06/09/1992 Inventor: Goldman, et al.5164371, Heterocyclic ketones Issued on: 11/17/1992 Inventor: Edwards, et al.5164388, Heterocyclic peptide renin inhibitors Issued on: 11/17/1992 Inventor: De, et al.5194614, Compounds having a naphthalene structure Issued on: 03/16/1993 Inventor: Andrieux, et al.5276051, Arylethylamine compounds Issued on: 01/04/1994 Inventor: Lesieur, et al.5281585, Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets Issued on: 01/25/1994 Inventor: Duggan, et al.5294713, 2-piperazinone compounds and their use Issued on: 03/15/1994 Inventor: Sugihara, et al.5443815, Technetium-99m labeled peptides for imaging Issued on: 08/22/1995 Inventor: Dean, et al.5492895, Inhibitors of thrombosis Issued on: 02/20/1996 Inventor: Vlasuk, et al.5521179, Heterocyclic amides Issued on: 05/28/1996 Inventor: Bernstein, et al.5523308, Peptidyl heterocycles useful in the treatment of thrombin related disorders Issued on: 06/04/1996 Inventor: Costanzo, et al.5563136, 3-Ureidobenzodiazepinones useful as antagonists of CCK or of gastrin Issued on: 10/08/1996 Inventor: Capet, et al.5583146, Heterocyclic thrombin inhibitors Issued on: 12/10/1996 Inventor: Kimball, et al.5612363, N,N-di(aryl) cyclic urea derivatives as anti-coagulants Issued on: 03/18/1997 Inventor: Mohan, et al.5618811, Tetrahydro-1H-benzazepinones and hexahydroazepinones as selective cholecystokinin-B receptor antagonists Issued on: 04/08/1997 Inventor: Lowe, III5632898, Method for removing unreacted electrophiles from a reaction mixture Issued on: 05/27/1997 Inventor: Jung, et al.5668289, Pyridinone thrombin inhibitors Issued on: 09/16/1997 Inventor: Sanderson, et al.5703208, 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors Issued on: 12/30/1997 Inventor: Semple, et al.5714499, 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors Issued on: 02/03/1998 Inventor: Semple, et al.5721214, Inhibitors of factor Xa Issued on: 02/24/1998 Inventor: Marlowe, et al.5776902, Boronophenyl analogs of phospholyrosines Issued on: 07/07/1998 Inventor: Bachovchin5861509, Arylglycinamide derivatives and pharmaceutical compositions containing these compounds Issued on: 01/19/1999 Inventor: Schnorrenberg, et al.5948785Heterocyclic amide compounds and pharmaceutical use of the same Issued on: 09/07/1999 Inventor: Akahoshi, et al.Foreign Patent References- 2 071 744 CA. 12/20/1992
- 2 126 026 CA. 12/20/1994
- 0 167 919 EP. 01/20/1986
- 0 239 461 EP. 09/20/1987
- 0 352 903 EP. 01/20/1990
- 0 365 992 EP. 05/20/1990
- 0 471 651 EP. 02/20/1992
- 0 512 831 EP. 11/20/1992
- 0 688 788 EP. 12/20/1995
- 0 761 220 EP. 03/20/1997
- 0 765 873 EP. 04/20/1997
- 0 529 858 EP. 03/20/1998
- 2 287 027 GB. 09/20/1995
- 53-34735 JP. 03/20/1978
- 58-96075 JP. 06/20/1983
- 58-194873 JP. 11/20/1983
- 58-216170 JP. 12/20/1983
- 2-83375 JP. 03/20/1990
- 3-148223 JP. 06/20/1991
- 5-241287 JP. 09/20/1993
- 6 327 488 JP. 11/20/1994
- 93/09133 WO. 05/20/1993
- 93/15756 WO. 08/20/1993
- 94/08941 WO. 04/20/1994
- WO 94/13648 WO. 06/20/1994
- 94/13693 WO. 06/20/1994
- 94/17817 WO. 08/20/1994
- 94/21673 WO. 09/20/1994
- 94/25051 WO. 10/20/1994
- 95/06038 WO. 03/20/1995
- WO 93/21213 WO. 10/20/1995
- WO 95/28399 WO. 10/20/1995
- 95/28420 WO. 10/20/1995
- 95/29189 WO. 11/20/1995
- 95/35308 WO. 12/20/1995
- 95/35312 WO. 12/20/1995
- 95/35311 WO. 12/20/1995
- 95/35313 WO. 12/20/1995
- 96/01338 WO. 01/20/1996
- 96/18644 WO. 06/20/1996
- 96/19491 WO. 06/20/1996
- 96/19483 WO. 06/20/1996
- 96/19493 WO. 06/20/1996
- 96/24609 WO. 08/20/1996
- 96/32110 WO. 10/20/1996
- 96/31214 WO. 10/20/1996
- 96/31504 WO. 10/20/1996
- 96/40744 WO. 12/20/1996
- 96/40653 WO. 12/20/1996
- 97/01338 WO. 01/20/1997
- 97/05160 WO. 02/20/1997
- 97/14417 WO. 04/20/1997
- 97/17363 WO. 05/20/1997
- 97/30073 WO. 08/20/1997
- 98/09987 WO. 03/20/1998
- 98/16547 WO. 04/20/1998
- 98/16523 WO. 04/20/1998
- 99/07732 WO. 02/20/1999
- 99/07731 WO. 02/20/1999
International Classes A61K 031/69 A61K 031/495 A61P 007/02 C07D 241/02 C07D 403/00
|